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Abstract3 
The tumor stage based on the American Joint Committee on Cancer / Union for International Cancer 
Control tumor node metastasis (TNM) system is considered the most important prognostic factor for 
patients with colorectal adenocarcinoma. Clinical decision-making including the application of adjuvant 
chemotherapy is greatly influenced by the presence of lymph node metastasis. The number of retrieved 
lymph nodes mainly depends on tumor-related factors, such as tumor size and depth of penetration, as 
well as procedure-related factors, including the extent and technique of surgical mesocolon/mesorectum 
removal and the skills and thoroughness of the pathologist. The lymph node ratio, defined as the number 
of positive lymph nodes divided by the total number of evaluated nodes, is a new marker. It may imply a 
higher prognostic significance than the absolute number of positive nodes alone. It is of note, that the 
pathologist’s lymph node harvest is dependent on the size of the lymph nodes. Thus, the diameter of 
lymph nodes, which are relevant to be histologically evaluated is a frequent matter of debate. The size of 
the lymph nodes is related to the risk of metastatic involvement, with the larger nodes more commonly 
positive for metastatic deposits than the smaller ones. However, statistical analysis based on multiple 
series of lymph nodes so far failed to determine a reliable cut-off value to predict metastatic disease. 
Thorough specimen dissection and the examination of lymph nodes smaller than 2mm can cause upstaging 
in approximately 30% of cases, but usually cannot identify additional node positive patients.                                                                      
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Introduction 
According to the statistics of the GLOBOCAN 
project colorectal adenocarcinoma is the third 
most common malignant tumor (excluding skin 
cancers), with 1.36 million new cases annually 
worldwide, and causing the death of almost 0.7 
million patients yearly [1]. The tumor stage based 
on the American Joint Committee on Cancer 
(AJCC)/ Union for International Cancer Control 
(UICC) tumor node metastasis (TNM) system [2] is 
considered the most important prognostic factor.  
The 5-year survival rate for patients with node-
negative disease is 70-80% compared to the 30-
60% for node-positive patients [3]. Clinical 
decision-making including the application of 
adjuvant chemotherapy is mainly based on the 
presence of lymph node metastasis, thus the 
method of pathological work-up by gross 
dissection and retrieval of lymph nodes for 
histological examination greatly influences 
treatment strategies of individual patients.  
A long lasting debate with many controversies 
exists on how the colorectal cancer specimen 
should be dissected, how many if not all lymph 
nodes should be sampled and/or whether there 
is a minimum number of lymph node that need to 
be investigated. In addition, it is still largely 
unclear how the size of the lymph nodes is 
related to the risk of metastatic involvement and 
how important the tiny lymph nodes are. 
Ideal number of lymph nodes to be 
sampled 
Although the absolute number of pathologically 
evaluated lymph nodes depends on many factors 
(Table 1), it is essential to assess the lymph node 
status reliably for adequate prognostication and 
therapy planning.  
To ensure that no metastatic lymph nodes will be 
missed due to undersampling, a minimum of 12 
lymph nodes were recommended by the 
AJCC/UICC TNM system based on the paper by 
Fielding et al. [2,4]. Nevertheless, the evidence 
for this particular number is weak and it does not 
seem to hold much biological significance; 
furthermore other authors suggested other 
minimum lymph node numbers [5]. In the light of 
some studies the prognosis of colorectal cancer 
improves with the number of lymph nodes 
sampled even in node negative cases [6], a 
phenomenon which is not fully understood and is 
most likely due to immunological factors.  
Based upon these data, it does not seem ideal to 
stop searching after the 12th lymph node is 
found, and in fact most guidelines recommend 
the histological examination of all grossly 
recognizable lymph nodes. Although audit of 
lymph node harvest can be a good tool for quality 
control, unfortunately the recommended number 
of harvested nodes is not reached in a significant 
number of cases, especially in left colectomy 
specimens, which can be as high as 80% in 
patients with rectal cancer after neoadjuvant 
therapy [7]. 
The extent of surgical lymph node sampling can 
be increased using certain procedures such as 
extended lymphadenectomy, high arterial 
ligation or total mesocolic excision (TME 
procedure), and it is important to note that the 
use of laparoscopic technique does not influence 
lymph node counts compared to open surgery 
[3]. 
Regarding the pathological work-up, many factors 
can influence the number of collected nodes: the 
applied national protocols, expertise and 
motivation of the dissector (e.g. non-pathologist, 
trainee or consultant), and most importantly the 
allocated time per specimen. According to the 
United Kingdom guidelines, 30-50 minutes of cut-
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up time should be anticipated in the case of usual 
colorectal resection specimens [8]. Based on the 
work of de Burlet et al., if an initial 20 minutes 
long lymph node search is extended by an 
additional 5 or 10 minutes, the yield can be 
increased by 12 or 20%, respectively [9].  
Over recent years several technical methods e.g. 
fat clearing, methylene blue injection, and 
acetone compression of adipose tissue [10] were 
developed to aid gross dissection and increase 
lymph node yield. These methods significantly 
increase the total number of examined lymph 
nodes, but according to some more recent 
publications these are not able to discover 
significantly more metastatic nodes [7,11]. 
 
Table 1  Parameters affecting the number of collected lymph nodes in colorectal 
cancer resection specimens 
Factors affecting the number of lymph nodes pathologically examined for staging in 
colorectal cancer 
Tumor-related factors 
• Tumor location 
• History of neoadjuvant treatment (in rectal cancer) 
• Tumor size (diameter) and depth of penetration (T classification) 
• Nodal status (N classification) 
Procedure-related Factors 
• Extent and technique of surgical mesocolon/mesorectum removal 
• Skills and thoroughness of the pathologist (time per specimen), including 
adherence to gross dissection guidelines 
Methods that may facilitate the recognition of lymph nodes: 
• Methylene blue injection 
• Fat clearing solution 
• Acetone compression 
 
Relevance of lymph node ratio 
Lymph node ratio is defined as the number of 
positive lymph nodes divided by the total number 
of evaluated nodes. Multiple studies 
demonstrated that the prognostic impact of the 
lymph node ratio is superior compared to the 
absolute number of metastatic nodes. Therefore, 
the lymph node ratio may improve the prognostic 
significance of the N-classification. It is of note 
that its prognostic impact may be related to the 
absolute number of retrieved nodes and may 
thus be related to the applied dissection 
technique. Optimal cut-off values for risk 
stratification still need to be defined [7].  
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Size of the retrieved lymph nodes 
As lymph node retrieval is dependent of lymph 
node size, the diameter of lymph nodes, which 
are ultimately relevant for prognostication of 
affected patients, is a frequent matter of debate. 
The size of the lymph node is related to the risk 
of metastatic involvement, with larger nodes 
being more commonly positive than smaller ones, 
but statistical analysis based on multiple series of 
lymph nodes so far failed to determine a reliable 
cut-off value to predict the presence of 
metastasis [12, 13, 14]. 
It is important to note that in a study carried out 
on a large series of lymph nodes almost half of 
the detected nodal metastases were in lymph 
nodes smaller than 5 mm [14]. Thorough 
specimen dissection and the identification of 
small (<2mm) lymph nodes can cause upstaging 
in up to 30% of the cases, but this does only 
rarely identify additional node positive patients 
[12]. 
How to deal with pericolic / 
extramural tumor deposits? 
Pericolic tumor deposits (PTD) are tumorous foci 
embedded in the pericolic (or perirectal) fat, with 
no connection to the primary tumor, and should 
be differentiated from metastatic lymph nodes, 
vascular spread and perineural invasion [2]. The 
presence of PTD carries a worse prognosis with 
increased local recurrence rates, increased risk of 
distant metastases and decreased survival.  
Several definitions of PTD have been used 
throughout the preceding editions of the 
AJCC/UICC TNM Staging Manual, illustrating how 
complex and arbitrary this category is. The 
definition of PTD and its distinction from 
metastatic lymph nodes (Figure 1) is crucial, but 
on the other hand probably the most difficult 
aspect of lymph node assessment, showing poor 
interobserver agreement even among experts [7]. 
The distinction should carefully be performed as 
it has direct impact on the N-classification and 
the metastatic as well as the absolute lymph 
node count.  
 
Figure 1a. Classical histological picture of lymph 
node metastasis of colorectal cancer and a typical 
pericolic tumor deposit  
 
Figure 1b. [Hematoxylin and Eosin, initial 
magnification x100] 
Deeper level sections of metastatic lymph nodes 
may show a morphology in keeping with the 
definition of PTD and vice versa. According to a 
meta-analysis 8% of patients with colorectal 
cancer have PTD without lymph node metastases, 
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in 18% a combination of lymph node metastases 
and PTD is found, in 28% only lymph node 
metastases were seen, whereas in 46% of cases 
no metastases were present [15]. The changing 
concept of PTD, which is still in progress, hampers 
its application in everyday routine practice. 
Conclusions 
Lymph node staging is the cornerstone of clinical 
decision making as well as therapy planning for 
patients with colorectal cancer. Many factors 
including the methods of pathological work-up 
can influence the number of examined lymph 
nodes, which can serve as a quality indicator. The 
adherence to current pathological guidelines and 
thorough specimen dissection with the allocation 
of sufficient time, are vital to produce reliable 
prognostic data. Although the evidence for the 
minimum number of harvested lymph nodes is 
week, the AJCC/UICC TNM Staging Manual 
recommends a minimal number of 12 nodes. As 
the examination of the lymph nodes smaller than 
2mm can cause upstaging in the N-classification 
in around one third of cases, the investigation of 
small lymph nodes seems relevant, although it 
rarely identifies patients as node-positive. The 
incorporation of the lymph node ratio in the 
pathology report is encouraged. The ever-
evolving concept of PTD still raises several 
problems that need to be solved in the future. 
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